𝔖 Bobbio Scriptorium

✦ LIBER ✦

OP-232 ROSUVASTATIN VERSUS ATORVASTATIN IN PREVENTING CONTRAST INDUCED NEPHROPATHY AMONG PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (ROSA-CIN TRIAL)

✍ Scribed by A. Kaya; M. Kurt; I.H. Tanboga; T. Isik; M. Ekinci; E. Aksakal; S. Sevimli

Book ID: 117354562
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 95 KB
Volume: 155
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(12)70153-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-Term, High-Dose Atorvastatin Pretr

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB

TCT-147 High dose Atorvastatin Pretreatm

TCT-147 High dose Atorvastatin Pretreatment for Preventing Contrast-Induced Nephropathy in Patients Receiving Primary Percutaneous Coronary Intervention: Prespecified Substudy of a Prospective Randomized Clinical trial

✍ Sang-Ho Jo; Hyun-Sook Kim; Jin-Ho Choi; Seung-Hyuk Choi; Joo-Yong Hahn; Sung Yun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Impact of Iso-Osmolar Versus Low-Osmolar

Impact of Iso-Osmolar Versus Low-Osmolar Contrast Agents on Contrast-Induced Nephropathy and Tissue Reperfusion in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (From the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial)

✍ Leonardo Bolognese; Giovanni Falsini; Carsten Schwenke; Simone Grotti; Ugo Limbr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 917 KB

Impact of High-Dose N-Acetylcysteine Ver

Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial

✍ Holger Thiele; Lysann Hildebrand; Carmen Schirdewahn; Ingo Eitel; Volker Adams; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB